Under a deal with the Trump administration in November, Novo Nordisk and Eli Lilly agreed to sell starter doses of their weight‑loss pills, if approved, for $US149 a month.
Pill version of injectable weight-loss drug Wegovy approved by US regulator
Published 3 hours ago
Source: abc.net.au
Categories
Pharmaceutical IndustryHealthObesityDiet and NutritionMedical ResearchPharmaceuticals
Related Articles from abc.net.au
5 hours ago
Woman accused of trying to kill ex allegedly searched for 'hit men'
6 hours ago
'Christmas will feel different this year': PM strikes sombre seasonal tone
6 hours ago
Nigerians welcome schoolchildren and teachers released after mass abduction
6 hours ago
Former federal Liberal MP Katie Allen dies aged 59
8 hours ago
Deadly snake becomes trapped in woman's shoe
8 hours ago